William Ho
2023 - RAPT Therapeutics
In 2023, William Ho earned a total compensation of $1.9M as Chief Medical Officer at RAPT Therapeutics, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $1,283,604 |
| Salary | $463,000 |
| Other | $7,322 |
| Total | $1,903,926 |
Ho received $1.3M in option awards, accounting for 67% of the total pay in 2023.
Ho also received $150K in non-equity incentive plan, $463K in salary and $7.3K in other compensation.
Rankings
In 2023, William Ho's compensation ranked 551st out of 2,816 executives tracked by ExecPay. In other words, Ho earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 551 out of 2,816 | 80th |
Division Manufacturing | 315 out of 1,551 | 80th |
Major group Chemicals And Allied Products | 222 out of 877 | 75th |
Industry group Drugs | 219 out of 840 | 74th |
Industry Pharmaceutical Preparations | 137 out of 605 | 77th |
Source: SEC filing on April 5, 2024.
Ho's colleagues
We found two more compensation records of executives who worked with William Ho at RAPT Therapeutics in 2023.
News
RAPT Therapeutics CEO Brian Wong's 2023 pay jumps 26% to $6.6M
April 5, 2024
RAPT Therapeutics CEO Brian Wong's 2022 pay jumps 84% to $5.2M
April 7, 2023
IN8BIO CEO William Ho's 2021 pay jumps 51% to $2.3M
April 22, 2022
RAPT Therapeutics CEO Brian Wong's 2021 pay falls 21% to $2.8M
April 11, 2022
RAPT Therapeutics CEO Brian Wong's 2020 pay jumps 86% to $3.6M
April 15, 2021
RAPT Therapeutics CFO Rodney Young receives $2.3M in 2019
April 29, 2020